Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial

被引：0
|
作者：
Hess, Connie N. [1 ,2 ]
Daffron, Ashley [3 ]
Nehler, Mark R. [2 ,4 ]
Szarek, Michael [1 ,2 ]
Cannon, Christopher P. [5 ]
Hsia, Judith [1 ,2 ]
Saseen, Joseph J. [3 ]
Bonaca, Marc P. [1 ,2 ]
机构：
[1] Univ Colorado, Sch Med, Dept Med, Div Cardiol, 2115 N Scranton St,Suite 2040, Aurora, CO 80045 USA
[2] CPC Clin Res, 2115 N Scranton St,Suite 2040, Aurora, CO 80045 USA
[3] Univ Colorado, Sch Pharm, Aurora, CO USA
[4] Univ Colorado, Sch Med, Dept Surg, Aurora, CO USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USA
来源：
VASCULAR MEDICINE | 2025年
基金：
芬兰科学院;
关键词：
implementation science; lipids; peripheral artery disease (PAD); statins;
D O I：
10.1177/1358863X241309839
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：3
相关论文
共 23 条
  • [1] Combination therapy lipid management in peripheral artery disease: insights from the OPTIMIZE PAD-1 trial
    Hess, Connie
    Dafrron, Ashley
    Nehler, Mark
    Morrison, Justin
    Buchanan, Cullen
    Saseen, Joseph
    Cannon, Christopher
    Hsia, Judith
    Bonaca, Marc
    VASCULAR MEDICINE, 2023, 28 (05) : 518 - 519
  • [2] LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study
    Catapano, A. L.
    Manu, M. C.
    Burden, A.
    Ray, K. K.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2373 - 2373
  • [3] Lipid-lowering therapy modification and LDL-C Goal achievement after an acute coronary syndrome: a prospective Swiss cohort
    Gencer, B.
    Mach, F.
    Auer, R.
    Raeber, L.
    Nanchen, D.
    Meyer, P.
    Matter, C. M.
    Windecker, S.
    Luescher, T. F.
    Rodondi, N.
    EUROPEAN HEART JOURNAL, 2013, 34 : 136 - 136
  • [4] LDL-C Goal Attainment According to Prescribed Lipid-Lowering Therapy: Results from the LIPIDE European Survey
    Desamericq, Gaelle
    Laforest, Laurent
    Schwalm, Marie-Sophie
    Moulin, Philippe
    Michel, Emilie
    Eteve, Caroline
    Coffin, Gabriel
    Ritleng, Cecile
    Van Ganse, Eric
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S154 - S154
  • [5] Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China
    Wang, Xing
    He, Yan
    Wang, Tao
    Li, Chunming
    Ma, Zihui
    Zhang, Heng
    Ma, Handong
    Zhao, Hongxin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (04) : 307 - 315
  • [6] Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
    van de Borne, Philippe
    Peeters, Andre
    Janssens, Luc
    Leone, Attilio
    Lemmens, Robin
    Verhaegen, Ann
    De Meulemeester, Marc
    Balthazar, Yohan
    Heijmans, Stephane
    Calozet, Yvan
    Paquot, Nicolas
    Carlier, Stephane
    Hemelsoet, Dimitri
    Bray, Sarah
    Ray, Kausik K.
    ACTA CARDIOLOGICA, 2024, 79 (01) : 20 - 29
  • [7] Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
    Zhang, Shuang
    Li, Zhi-Fan
    Shi, Hui-Wei
    Zhang, Wen-Jia
    Sui, Yong-Gang
    Li, Jian-Jun
    Dou, Ke-Fei
    Qian, Jie
    Wu, Na-Qiong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] The journey to LDL-C goal in the era of combination lipid lowering therapy and why it matters for ASCVD patients: a UK perspective
    Elnaggar, Mohamed
    Miller, Ashley M.
    Sil, Arunesh
    Viljoen, Adie
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (10) : 1673 - 1683
  • [9] ACHIEVEMENT OF LDL-C GOALS IN PATIENTS AT MODERATE TO VERY HIGH CARDIOVASCULAR RISK ON LIPID-LOWERING DRUG THERAPY (CEPHEUS II)
    Logunova, Natalia
    Gurina, Natalia
    Boytsov, Sergey
    ATHEROSCLEROSIS, 2017, 263 : E236 - E237
  • [10] LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease
    van de Woestijne, Anton P.
    van der Graaf, Yolanda
    de Bakker, Paul I. W.
    Asselbergs, Folkert W.
    de Borst, Gert Jan
    Algra, Ale
    Spiering, Wilko
    Visseren, Frank L. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (02) : 184 - 191
123